M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Akari Therapeutics PLC to acquire Peak Bio
Announced May 1, 2024 · Closed Nov 14, 2024 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Akari Therapeutics PLC (AKTX)
- Target
- Peak Bio
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Nov 14, 2024
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations